Search Results - "Leerdam, Monique"

Colonoscopy surveillance: striving toward less is more? by van Leerdam, Monique E

Get more information

Neoadjuvant immunotherapy leads to pathological responses in MMR-proficient and MMR-deficient early-stage colon cancers by Chalabi, Myriam, Fanchi, Lorenzo F., Dijkstra, Krijn K., Van den Berg, José G., Aalbers, Arend G., Sikorska, Karolina, Lopez-Yurda, Marta, Grootscholten, Cecile, Beets, Geerard L., Snaebjornsson, Petur, Maas, Monique, Mertz, Marjolijn, Veninga, Vivien, Bounova, Gergana, Broeks, Annegien, Beets-Tan, Regina G., de Wijkerslooth, Thomas R., van Lent, Anja U., Marsman, Hendrik A., Nuijten, Elvira, Kok, Niels F., Kuiper, Maria, Verbeek, Wieke H., Kok, Marleen, Van Leerdam, Monique E., Schumacher, Ton N., Voest, Emile E., Haanen, John B.

“…PD-1 plus CTLA-4 blockade is highly effective in advanced-stage, mismatch repair (MMR)-deficient (dMMR) colorectal cancers, yet not in MMR-proficient (pMMR)…”
Get full text

Generation of Tumor-Reactive T Cells by Co-culture of Peripheral Blood Lymphocytes and Tumor Organoids by Dijkstra, Krijn K., Cattaneo, Chiara M., Weeber, Fleur, Chalabi, Myriam, van de Haar, Joris, Fanchi, Lorenzo F., Slagter, Maarten, van der Velden, Daphne L., Kaing, Sovann, Kelderman, Sander, van Rooij, Nienke, van Leerdam, Monique E., Depla, Annekatrien, Smit, Egbert F., Hartemink, Koen J., de Groot, Rosa, Wolkers, Monika C., Sachs, Norman, Snaebjornsson, Petur, Monkhorst, Kim, Haanen, John, Clevers, Hans, Schumacher, Ton N., Voest, Emile E.

“…Cancer immunotherapies have shown substantial clinical activity for a subset of patients with epithelial cancers. Still, technological platforms to study…”
Get full text

Preface Hereditary disorders by van Leerdam, Monique E., Ricciardiello, Luigi

Get full text

Guaiac-based faecal occult blood tests versus faecal immunochemical tests for colorectal cancer screening in average-risk individuals by Grobbee, Esmée J, Wisse, Pieter HA, Schreuders, Eline H, van Roon, Aafke, van Dam, Leonie, Zauber, Ann G, Lansdorp-Vogelaar, Iris, Bramer, Wichor, Berhane, Sarah, Deeks, Jonathan J, Steyerberg, Ewout W, van Leerdam, Monique E, Spaander, Manon Cw, Kuipers, Ernst J

“…Worldwide, many countries have adopted colorectal cancer (CRC) screening programmes, often based on faecal occult blood tests (FOBTs). CRC screening aims to…”
Get more information

Platinum retention in plasma, urine, and normal colonic mucosa in cisplatin-treated testicular cancer survivors by Breekveldt, Emilie C. H, Ykema, Berbel L. M, Huitema, Alwin D. R, Gietema, Jourik A, Beijnen, Jos H, Snaebjornsson, Petur, Schaapveld, Michael, van Leeuwen, Flora E, Rosing, Hilde, van Leerdam, Monique E

“…Testicular cancer survivors (TCS) treated with platinum-based chemotherapy have increased cancer risk. Platinum retention in healthy tissue may contribute to…”
Get full text

Predictive Value of Endoscopic Features for a Complete Response After Chemoradiotherapy for Rectal Cancer by van der Sande, Marit E., Maas, Monique, Melenhorst, Jarno, Breukink, Stéphanie O., van Leerdam, Monique E., Beets, Geerard L.

“…OBJECTIVE AND BACKGROUND:Watch-and-wait approach in rectal cancer relies on the identification of a clinical complete response (CR) after neoadjuvant…”
Get full text

Prevalence of Sarcopenia and Impact on Survival in Patients with Metastatic Gastroenteropancreatic Neuroendocrine Tumours by Clement, Dominique S V M, Leerdam, Monique E van, de Jong, Soraya, Weickert, Martin O, Ramage, John K, Tesselaar, Margot E T, Srirajaskanthan, Rajaventhan

“…Sarcopenia in patients with cancer is associated with adverse outcomes such as shorter survival. However, there exists little evidence regarding the prevalence…”
Get full text

Development and validation of the WASP classification system for optical diagnosis of adenomas, hyperplastic polyps and sessile serrated adenomas/polyps by IJspeert, Joep E G, Bastiaansen, Barbara A J, van Leerdam, Monique E, Meijer, Gerrit A, van Eeden, Susanne, Sanduleanu, Silvia, Schoon, Erik J, Bisseling, Tanya M, Spaander, Manon Cw, van Lelyveld, Niels, Bargeman, Marloes, Wang, Junfeng, Dekker, Evelien

“…Accurate endoscopic differentiation would enable to resect and discard small and diminutive colonic lesions, thereby increasing cost-efficiency. Current…”
Get more information

Emerge of colorectal cancer in Lynch syndrome despite colonoscopy surveillance: A challenge of hide and seek by Helderman, Noah C., van Leerdam, Monique E., Kloor, Matthias, Ahadova, Aysel, Nielsen, Maartje

“…Even with colonoscopy surveillance, Lynch syndromes (LS) carriers still develop colorectal cancer (CRC). The cumulative incidence of CRCs under colonoscopy…”
Get full text

Sarcopenia and Neuroendocrine Neoplasms by Clement, Dominique, Brown, Sarah, Leerdam, Monique V., Tesselaar, Margot, Ramage, John, Srirajaskanthan, Rajaventhan

“…Purpose of the Review To summarise the current literature regarding the presence of sarcopenia in patients with neuroendocrine neoplasms (NENs). These are…”
Get full text

Participation and yield of colonoscopy versus non-cathartic CT colonography in population-based screening for colorectal cancer: a randomised controlled trial by Stoop, Esther M, MD, de Haan, Margriet C, MD, de Wijkerslooth, Thomas R, MD, Bossuyt, Patrick M, Prof, van Ballegooijen, Marjolein, MD, Nio, C Yung, MD, van de Vijver, Marc J, Prof, Biermann, Katharina, MD, Thomeer, Maarten, MD, van Leerdam, Monique E, MD, Fockens, Paul, Prof, Stoker, Jaap, Prof, Kuipers, Ernst J, Prof, Dekker, Evelien, Dr

“…Summary Background Screening for colorectal cancer is widely recommended, but the preferred strategy remains unidentified. We aimed to compare participation…”
Get full text

The Management of Peutz-Jeghers Syndrome: European Hereditary Tumour Group (EHTG) Guideline by Wagner, Anja, Aretz, Stefan, Auranen, Annika, Bruno, Marco J, Cavestro, Giulia M, Crosbie, Emma J, Goverde, Anne, Jelsig, Anne Marie, Latchford, Andrew, Leerdam, Monique E van, Lepisto, Anna, Puzzono, Marta, Winship, Ingrid, Zuber, Veronica, Möslein, Gabriela

“…The scientific data to guide the management of Peutz-Jeghers syndrome (PJS) are sparse. The available evidence has been reviewed and discussed by diverse…”
Get full text

Endoscopic management of Lynch syndrome and of familial risk of colorectal cancer: European Society of Gastrointestinal Endoscopy (ESGE) Guideline by van Leerdam, Monique E, Roos, Victorine H, van Hooft, Jeanin E, Balaguer, Francesc, Dekker, Evelien, Kaminski, Michal F, Latchford, Andrew, Neumann, Helmut, Ricciardiello, Luigi, Rupińska, Maria, Saurin, Jean-Christophe, Tanis, Pieter J, Wagner, Anja, Jover, Rodrigo, Pellisé, Maria

“…ESGE recommends that individuals with Lynch syndrome should be followed in dedicated units that practice monitoring of compliance and endoscopic performance…”
Get more information

Impact of COVID-19 and suspension of colorectal cancer screening on incidence and stage distribution of colorectal cancers in the Netherlands by Toes-Zoutendijk, Esther, Vink, Geraldine, Nagtegaal, Iris D., Spaander, Manon C.W., Dekker, Evelien, van Leerdam, Monique E., Siesling, Sabine, Lansdorp-Vogelaar, Iris, Elferink, Marloes A.G.

“…Many countries had to suspend their colorectal cancer (CRC) screening programme as a result of the COVID-19 pandemic. This eventually may lead to postponed…”
Get full text

The global leadership into malnutrition criteria reveals a high percentage of malnutrition which influences overall survival in patients with gastroenteropancreatic neuroendocrine tumours by Clement, Dominique S. V. M., Leerdam, Monique E., Tesselaar, Margot E. T., Cananea, Elmie, Martin, Wendy, Weickert, Martin O., Sarker, Debashis, Ramage, John K., Srirajaskanthan, Rajaventhan

“…Patients with neuroendocrine tumours located in the gastroenteropancreatic tract (GEP‐NETs) and treatment with somatostatin analogues (SSA's) are at risk of…”
Get full text

The multitarget faecal immunochemical test for improving stool-based colorectal cancer screening programmes: a Dutch population-based, paired-design, intervention study by Wisse, Pieter H A, de Klaver, Willemijn, van Wifferen, Francine, van Maaren-Meijer, Frejanne G, van Ingen, Huub E, Meiqari, Lana, Huitink, Iris, Bierkens, Mariska, Lemmens, Margriet, Greuter, Marjolein J E, van Leerdam, Monique E, Spaander, Manon C W, Dekker, Evelien, Coupé, Veerle M H, Carvalho, Beatriz, de Wit, Meike, Meijer, Gerrit A

“…The faecal immunochemical test (FIT) is widely employed for colorectal cancer screening. However, its sensitivity for advanced precursor lesions remains…”
Get full text

The national FIT-based colorectal cancer screening program in the Netherlands during the COVID-19 pandemic by Kortlever, Tim L., de Jonge, Lucie, Wisse, Pieter H.A., Seriese, Iris, Otto-Terlouw, Patricia, van Leerdam, Monique E., Spaander, Manon C.W., Dekker, Evelien, Lansdorp-Vogelaar, Iris

“…The COVID-19 pandemic has affected many healthcare services worldwide. Like many other nations, the Netherlands experienced large numbers of individuals…”
Get full text

The second round of the Dutch colorectal cancer screening program: Impact of an increased fecal immunochemical test cut‐off level on yield of screening by Kooyker, Arthur I., Toes‐Zoutendijk, Esther, Opstal‐van Winden, Annemieke W.J., Spaander, Manon C.W., Buskermolen, Maaike, Vuuren, Hanneke J., Kuipers, Ernst J., Kemenade, Folkert J., Ramakers, Chris, Thomeer, Maarten G.J., Dekker, Evelien, Nagtegaal, Iris D., Koning, Harry J., Leerdam, Monique E., Lansdorp‐Vogelaar, Iris

“…The Dutch colorectal cancer (CRC) screening program started in 2014, inviting the target population biennially to perform a fecal immunochemical test (FIT). We…”
Get full text

Pancreatic Cancer Surveillance in Carriers of a Germline CDKN2A Pathogenic Variant: Yield and Outcomes of a 20-Year Prospective Follow-Up by Klatte, Derk C F, Boekestijn, Bas, Wasser, Martin N J M, Feshtali Shahbazi, Shirin, Ibrahim, Isaura S, Mieog, J Sven D, Luelmo, Saskia A C, Morreau, Hans, Potjer, Thomas P, Inderson, Akin, Boonstra, Jurjen J, Dekker, Friedo W, Vasen, Hans F A, van Hooft, Jeanin E, Bonsing, Bert A, van Leerdam, Monique E

“…Pancreatic cancer surveillance in high-risk individuals may lead to detection of pancreatic ductal adenocarcinoma (PDAC) at an earlier stage and with improved…”
Get full text